Cargando…

TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cells

Following activation by cognate antigen, B cells undergo fine-tuning of their antigen receptors and may ultimately differentiate into antibody-secreting cells (ASCs). While antigen-specific B cells that express surface receptors (B cell receptors [BCRs]) can be readily cloned and sequenced following...

Descripción completa

Detalles Bibliográficos
Autores principales: Asrat, Seblewongel, Devlin, Joseph C., Vecchione, Andrea, Klotz, Brian, Setliff, Ian, Srivastava, Devin, Limnander, Andre, Rafique, Ashique, Adler, Christina, Porter, Stephen, Murphy, Andrew J., Atwal, Gurinder S., Sleeman, Matthew A., Lim, Wei Keat, Orengo, Jamie M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391570/
https://www.ncbi.nlm.nih.gov/pubmed/37533642
http://dx.doi.org/10.1016/j.crmeth.2023.100522
Descripción
Sumario:Following activation by cognate antigen, B cells undergo fine-tuning of their antigen receptors and may ultimately differentiate into antibody-secreting cells (ASCs). While antigen-specific B cells that express surface receptors (B cell receptors [BCRs]) can be readily cloned and sequenced following flow sorting, antigen-specific ASCs that lack surface BCRs cannot be easily profiled. Here, we report an approach, TRAPnSeq (antigen specificity mapping through immunoglobulin [Ig] secretion TRAP and Sequencing), that allows capture of secreted antibodies on the surface of ASCs, which in turn enables high-throughput screening of single ASCs against large antigen panels. This approach incorporates flow cytometry, standard microfluidic platforms, and DNA-barcoding technologies to characterize antigen-specific ASCs through single-cell V(D)J, RNA, and antigen barcode sequencing. We show the utility of TRAPnSeq by profiling antigen-specific IgG and IgE ASCs from both mice and humans and highlight its capacity to accelerate therapeutic antibody discovery from ASCs.